Fig. 2: Time-to-first-treatment (TTFT) in Binet A CLL patients carrying recurrent gene mutations stratified based on IGHV gene SHM status.
Pairwise comparisons were performed using the Cox–Mantel log-rank test. U-CLL, CLL with unmutated IGHV genes, M-CLL, CLL with mutated IGHV genes.
